Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
VGB-R04
GENETIC
2 trials
Sponsors
Institute of Hematology & Blood Diseases Hospital, China
, Shanghai Vitalgen BioPharma Co., Ltd.
Conditions
Hemophilia B
Early Phase 1
Safety and Tolerability of VGB-R04 in Patients With Haemophilia B
Recruiting
NCT05152732
Institute of Hematology & Blood Diseases Hospital, China
Hemophilia B
Start: 2021-12-28
End: 2025-12-31
Target: 3
Updated: 2025-02-21
Phase 1
A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients
NCT05441553
Shanghai Vitalgen BioPharma Co., Ltd.
Hemophilia B
Start: 2022-07-31
End: 2025-01-31
Target: 26
Updated: 2022-07-01